0,933  0,004  Antineoplastic (breast cancer)
0,923  0,005  Apoptosis agonist
0,906  0,005  Antiinflammatory
0,892  0,005  Antineoplastic (lung cancer)
0,870  0,004  Caspase 9 stimulant
0,860  0,004  Antineoplastic (ovarian cancer)
0,859  0,005  Antineoplastic (colorectal cancer)
0,859  0,005  Antineoplastic (colon cancer)
0,805  0,005  Antineoplastic (melanoma)
0,798  0,004  Nitric oxide antagonist
0,792  0,006  Antileukemic
0,767  0,007  Chemopreventive
0,734  0,003  Antineoplastic (endocrine cancer)
0,664  0,012  Prostate cancer treatment
0,661  0,025  Transcription factor NF kappa B inhibitor
0,633  0,007  Antineoplastic (glioma)
0,616  0,009  Antineoplastic (pancreatic cancer)
0,612  0,008  Apoptosis antagonist
0,613  0,010  AR expression inhibitor
0,589  0,006  Antineoplastic (glioblastoma multiforme)
0,591  0,009  Antifungal
0,590  0,010  Antineoplastic (brain cancer)
0,573  0,007  Antineoplastic (lymphoma)
0,562  0,016  Cytotoxic
0,542  0,014  Antineoplastic (multiple myeloma)
0,530  0,008  Antineoplastic (carcinoma)
0,548  0,029  Antibacterial
0,525  0,008  Antihypoxic
0,551  0,034  TNF expression inhibitor
0,523  0,008  ICAM1 expression inhibitor
0,511  0,005  Contraceptive
0,519  0,019  Hepatic disorders treatment
0,497  0,007  Hepatoprotectant
0,493  0,005  Antineoplastic (gastric cancer)
0,508  0,031  Cholesterol antagonist
0,492  0,023  Antineoplastic (cervical cancer)
0,466  0,008  Abortion inducer
0,477  0,024  Caspase 3 stimulant
0,464  0,025  NOS3 expression inhibitor
0,452  0,014  Antineoplastic (renal cancer)
0,431  0,024  UGT2B4 substrate
0,426  0,028  NOS2 expression inhibitor
0,405  0,010  Prostate disorders treatment
0,407  0,015  Sodium/bile acid cotransporter inhibitor
0,403  0,010  Interferon gamma antagonist
0,410  0,020  Angiogenesis stimulant
0,394  0,005  Antineoplastic antibiotic
0,408  0,022  Antineoplastic (liver cancer)
0,418  0,032  Chemoprotective
0,389  0,005  Contraceptive male
0,384  0,005  Antiinfertility, female
0,391  0,016  Antiviral (HIV)
0,381  0,012  Phospholipase C inhibitor
0,382  0,013  UGT2B7 substrate
0,378  0,013  Antiviral (Influenza)
0,410  0,059  Immunosuppressant
0,356  0,010  Antiviral (Influenza A)
0,355  0,013  Lipocortins synthesis antagonist
0,374  0,038  Hypoxia-inducible factor 1 alpha inhibitor
0,399  0,067  Antipruritic, allergic
0,358  0,033  Myocardial infarction treatment
0,331  0,008  Cholesterol synthesis inhibitor
0,348  0,027  UDP-glucuronosyltransferase substrate
0,338  0,017  Melanin inhibitor
0,382  0,067  CYP3A4 substrate
0,314  0,015  Sepsis treatment
0,319  0,020  Prostatic (benign) hyperplasia treatment
0,311  0,015  Protein kinase stimulant
0,348  0,052  Cardioprotectant
0,342  0,048  Antioxidant
0,329  0,035  Antineoplastic (lymphocytic leukemia)
0,356  0,062  Antithrombotic
0,346  0,053  Antihypercholesterolemic
0,336  0,043  Proliferative diseases treatment
0,308  0,016  Neurotrophic factor enhancer
0,302  0,010  Protein-tyrosine phosphatase 1B inhibitor
0,308  0,030  UGT1A1 substrate
0,316  0,048  Tumour necrosis factor alpha release inhibitor
0,272  0,005  Transcription factor NF kappa B stimulant
0,321  0,056  Antineoplastic (osteosarcoma)
0,288  0,025  Antiviral (Herpes)
0,271  0,014  Antifungal enhancer
0,280  0,024  Antiacne
0,279  0,023  Protein-tyrosine phosphatase inhibitor
0,321  0,073  Immunostimulant
0,252  0,019  UGT2B9 substrate
0,248  0,015  Cell adhesion inhibitor
0,239  0,008  Arachidonic acid antagonist
0,269  0,039  Antihelmintic
0,232  0,013  Microtubule formation inhibitor
0,242  0,025  Interleukin 6 antagonist
0,267  0,054  Antiparasitic
0,222  0,011  Contraceptive female
0,238  0,033  Antineoplastic (squamous cell carcinoma)
0,225  0,022  DNA polymerase I inhibitor
0,247  0,050  Platelet adhesion inhibitor
0,224  0,031  Acute respiratory distress syndrome (ARDS) treatment
0,193  0,002  Na+ K+ transporting ATPase inhibitor
0,308  0,118  Antiprotozoal
0,279  0,090  Interleukin 2 agonist
0,212  0,025  Antiviral (Hepatitis B)
0,214  0,028  UGT2B10 substrate
0,259  0,078  UGT1A9 substrate
0,264  0,083  5 Hydroxytryptamine release stimulant
0,251  0,072  Antiprotozoal (Leishmania)
0,243  0,073  Vasodilator
0,230  0,065  Antihypertriglyceridemic
0,186  0,021  Growth stimulant
0,188  0,026  Farnesoid X receptor antagonist
0,213  0,053  Antipruritic, non-allergic
0,182  0,028  Antihemorrhagic
0,157  0,007  Androgen agonist
0,177  0,028  Adenylate cyclase stimulant
0,171  0,024  Choleretic
0,192  0,046  UGT2B15 substrate
0,149  0,008  Glycine receptor antagonist
0,197  0,059  UGT1A4 substrate
0,152  0,014  UGT2B11 substrate
0,226  0,092  Hypoglycemic
0,219  0,092  Cardiovascular analeptic
0,228  0,103  Lipoprotein disorders treatment
0,234  0,110  Respiratory analeptic
0,201  0,079  Sensitization
0,147  0,036  Alcohol dehydrogenase substrate
0,116  0,008  Antitreponemal
0,166  0,058  Lipid peroxidase inhibitor
0,145  0,037  Expectorant
0,132  0,029  Anabolic
0,206  0,103  Antipyretic
0,132  0,033  Toll-Like receptor 4 antagonist
0,256  0,158  Atherosclerosis treatment
0,174  0,077  Antirickettsial
0,103  0,006  RNA-directed RNA polymerase stimulant
0,100  0,005  Acetyl-CoA transferase 2 inhibitor
0,098  0,008  Heme oxygenase stimulant
0,150  0,059  Antifungal (Cryptococcus)
0,120  0,030  SULT1E1 substrate
0,144  0,054  Cyclooxygenase 3 inhibitor
0,157  0,067  Insulin secretagoues
0,145  0,058  Skin whitener
0,090  0,003  Tubulin agonist
0,092  0,008  Lipocortins synthesis agonist
0,101  0,017  Anticholelithogenic
0,203  0,121  Antineoplastic (sarcoma)
0,191  0,111  Peptidyltransferase inhibitor
0,155  0,081  Antihelmintic (Nematodes)
0,183  0,110  UGT1A6 substrate
0,105  0,032  Antibiotic
0,160  0,091  Toxic, respiratory center
0,151  0,082  UGT1A3 substrate
0,199  0,134  Analeptic
0,069  0,007  Microtubule stabilization
0,068  0,006  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,198  0,137  Transcription factor STAT3 inhibitor
0,080  0,020  Protein 50S ribosomal subunit inhibitor
0,080  0,022  Antimycoplasmal
0,075  0,017  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,077  0,023  Postmenopausal disorders treatment
0,157  0,106  P-glycoprotein inhibitor
0,180  0,130  Vascular (periferal) disease treatment
0,175  0,126  Antineoplastic (non-small cell lung cancer)
0,199  0,150  Gastrin inhibitor
0,083  0,034  Glycine receptor agonist
0,067  0,024  Postcoital contraceptive
0,098  0,055  Bile acid receptor antagonist
0,052  0,011  Glucose-6-phosphate dehydrogenase inhibitor
0,092  0,053  Ornithine decarboxylase inhibitor
0,040  0,002  Telomerase stimulant
0,073  0,036  SULT2A1 substrate
0,048  0,012  Cholesterol absorption inhibitor
0,124  0,090  Psychosexual dysfunction treatment
0,158  0,129  Hypolipemic
0,087  0,058  Androgen antagonist
0,092  0,065  Antischistosomal
0,053  0,031  Anesthetic inhalation
0,088  0,066  Paget's disease treatment
0,163  0,141  Cytostatic
0,177  0,157  DNA synthesis inhibitor
0,028  0,008  Corticosteroid-like
0,029  0,011  Estrone sulfatase inhibitor
0,163  0,146  VCAM1 expression inhibitor
0,039  0,022  Antibiotic Aminoglycoside-like
0,142  0,128  Antiviral (Hepatitis)
0,029  0,016  Hedgehog signaling activator
0,022  0,009  Progesterone agonist
0,103  0,092  Estrogen antagonist
0,092  0,082  AMP-activated protein kinase stimulant
0,047  0,038  Estrogen agonist
0,079  0,071  T cell inhibitor
0,085  0,078  Anticataract
0,091  0,085  UGT2B1 substrate
0,179  0,175  Bone diseases treatment
0,048  0,046  Acetyl-CoA transferase inhibitor

